Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Nashville,, TN
SEC filing record 1 source field available
Fiscal year end
31 December
CUMBERLAND PHARMACEUTICALS INC has filed 1,032 SEC EDGAR filings since 02 May 2002

SEC filing history

Showing 401-425 of 959 matching filings.

Per page
25
Current page
17
8-K File 001-33637

8-K

Filing date
10 Nov 2020
Reporting date
10 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
20 Oct 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
16 Oct 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K FOURTH AMENDMENT TO REVOLVING LINE OF CREDIT

Filing date
09 Oct 2020
Reporting date
09 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
23 Sep 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
18 Sep 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Aug 2020
Reporting date
10 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K

Filing date
11 Aug 2020
Reporting date
11 Aug 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
22 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
08 Jul 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Jun 2020
Reporting date
13 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K

Filing date
29 May 2020
Reporting date
29 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K

Filing date
20 May 2020
Reporting date
20 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K

Filing date
08 May 2020
Reporting date
08 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K

Filing date
08 May 2020
Reporting date
08 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K

Filing date
01 May 2020
Reporting date
01 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33637

8-K

Filing date
21 Apr 2020
Reporting date
21 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Apr 2020
Reporting date
23 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Apr 2020
Reporting date
23 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Apr 2020
Reporting date
23 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Apr 2020
Reporting date
23 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Apr 2020
Reporting date
23 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .